Adimab, Mersana to combine antibody technologies
12:46 EDT 1 Aug 2012 | BioCentury
Adimab LLC (Lebanon, N.H.) and Mersana Therapeutics Inc. (Cambridge, Mass.) partnered to offer integrated access to Adimab's yeast-based antibody discovery technology and Mersana's antibody-drug conjugate (ADC) platform. Mersana's ADC platform consis..
Original Article: Adimab, Mersana to combine antibody technologies
More From BioPortfolio on "Adimab, Mersana to combine antibody technologies"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
